BIOMAT Database Logo BIOMAT Database Logo

[Use of carminomycin in bladder cancer]. 1979

B I Zak, and V P Korol'chuk, and V G Abrazheev, and T I Vakulina, and G A Skriabnev

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002360 Carubicin A very toxic anthracycline-type antineoplastic related to DAUNORUBICIN, obtained from Actinomadura carminata. Carminomycin,Karminomycin,Carminomicin,Carminomycin I,Carminomycin II,Carminomycin III,Carubicin Hydrochloride,Demethyldaunomycin,Demethyldaunorubicin,Karminomicin,NSC-180,024,NSC-180024,Rubeomycin A,Rubeomycin A1,Hydrochloride, Carubicin,NSC 180,024,NSC 180024,NSC180,024,NSC180024
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

B I Zak, and V P Korol'chuk, and V G Abrazheev, and T I Vakulina, and G A Skriabnev
[Carminomycin study in breast cancer].
May 1978, Antibiotiki,
B I Zak, and V P Korol'chuk, and V G Abrazheev, and T I Vakulina, and G A Skriabnev
[Therapeutic use of carminomycin in soft tissue sarcomas].
July 1976, Antibiotiki,
B I Zak, and V P Korol'chuk, and V G Abrazheev, and T I Vakulina, and G A Skriabnev
[Use of carminomycin in adults with acute leukemia].
January 1984, Klinicheskaia meditsina,
B I Zak, and V P Korol'chuk, and V G Abrazheev, and T I Vakulina, and G A Skriabnev
[Therapeutic use of carminomycin in Ewing's sarcoma in children].
January 1979, Antibiotiki,
B I Zak, and V P Korol'chuk, and V G Abrazheev, and T I Vakulina, and G A Skriabnev
[Use of carminomycin on adult patients with acute leukemias].
August 1977, Antibiotiki,
B I Zak, and V P Korol'chuk, and V G Abrazheev, and T I Vakulina, and G A Skriabnev
[Use of carminomycin on children and adolescents with osteogenic sarcoma].
February 1979, Antibiotiki,
B I Zak, and V P Korol'chuk, and V G Abrazheev, and T I Vakulina, and G A Skriabnev
Antitumor antibiotic carminomycin.
January 1980, Zeitschrift fur allgemeine Mikrobiologie,
B I Zak, and V P Korol'chuk, and V G Abrazheev, and T I Vakulina, and G A Skriabnev
[Carminomycin in drug combination in breast cancer and soft tissue sarcomas].
October 1977, Antibiotiki,
B I Zak, and V P Korol'chuk, and V G Abrazheev, and T I Vakulina, and G A Skriabnev
Use of selenium in chemoprevention of bladder cancer.
September 2006, The Lancet. Oncology,
B I Zak, and V P Korol'chuk, and V G Abrazheev, and T I Vakulina, and G A Skriabnev
[Use of carminomycin in combination with UHF hyperthermia in the therapy of sarcoma 180].
August 1979, Antibiotiki,
Copied contents to your clipboard!